Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Nyxoah ( (NYXH) ) has shared an announcement.
Nyxoah SA announced it received a transparency notification from BlackRock, Inc., revealing that BlackRock and its subsidiaries hold 1,124,630 voting rights in Nyxoah, amounting to 3% of the total voting rights as of December 17, 2024. This acquisition indicates BlackRock’s strategic interest in Nyxoah, potentially impacting the company’s market position and signaling confidence in its growth prospects within the medical technology sector.
More about Nyxoah
Nyxoah SA operates within the medical technology industry and is listed on Euronext Brussels and Nasdaq. The company focuses on developing innovative solutions for the treatment of obstructive sleep apnea, a market that is expanding due to increased awareness and diagnosis of sleep disorders.
Average Trading Volume: 81,216
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $294.2M
For detailed information about NYXH stock, go to TipRanks’ Stock Analysis page.
